the particulars under (1)(2) and (3) shall be in accordance with the Forms specified in Clause 16, Clause 19, Clause 20, Clause 21/3, Clause 21/4 or Clause 21/5, as the case may be: (1) fact sheet; (2
งวดไตรมาสลาสุด เอกสารแนบ 6 อื่นๆ - 6 - สวนท่ี 1 สรุปขอมูลสําคัญของตราสาร (fact sheet) ใหสรุปสาระสําคัญของตราสาร รวมท้ังลักษณะพิเศษและความเส่ียงที่สําคัญของตราสาร - 7 - สวนท่ี 2 ขอมูลสรุป
- commissioning activities planned in December 2017 and startup early 2018. In addition to improved cash flows as a result of the better performance, the Company’s Balance Sheet al- so strengthened as a consequence
sheet and cash flow generation are strong, allowing us to invest significantly in our growth engines, through selective growth and turnaround opportunities, leveraging our strengths in core markets and in
earnings. IVL balance sheet and cash flow generation are strong, allowing us to invest significantly in our growth engines, through selective growth and turnaround opportunities, leveraging our strengths in
, diversified and steady cash flows making it a unique world-class chemical company. This acquisition will be funded by cash and debt and there is no equity dilution anticipated. IVL balance sheet was
continued to outperform Core EPS of THB 3.86, delivering earnings growth for the 18th consecutive quarter Operating Cash Flow of $923 million, helps strengthen balance sheet and fund future growth
announced our joint support for chemical recycling of PET waste in the Netherlands which is expected in 4Q19. Stronger Balance Sheet with Prudent Growth IVL business model has evolved over the years with
30,000 40,000 50,000 60,000 70,000 80,000 Total Assets Total Liabilities Total Shareholder Equity 2017 Q12018 Unit : THB mm The changes in Consolidated Balance Sheet as of 31 March 2018 are summarized as
การเปดเผยขอมูลของผูออก DW 1.1 การเปดเผยขอมูลในแบบแสดงรายการขอมูล 69-DW-full (“แบบ filing”) ซึ่งประกอบดวยขอมูลดังนี้ - สรุปสาระขอมูลสําคัญของตราสาร (fact sheet) - ขอมูลสรุป (executive summary